Dr. Jorde is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
Ph 12
New York, NY 10032Phone+1 212-305-9264
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 1996 - 1999
- Icahn School of Medicine at Mount SinaiResidency, Internal Medicine/Pediatrics, 1993 - 1995
- University Hamburg, Krankenhaus Eppendorf, Fak MedClass of 1991
Certifications & Licensure
- NY State Medical License 1996 - 2025
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
Clinical Trials
- Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity Start of enrollment: 2005 Nov 01
- The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure Start of enrollment: 2010 Jan 01
- REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 47 citationsCombination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunctionMaryjane Farr, James M. Mitchell, Matthew Lippel, Tomoko S. Kato, Zhezhen Jin
The Journal of Heart and Lung Transplantation. 2014-04-01 - 71 citationsUsefulness of Two-Dimensional Echocardiographic Parameters of the Left Side of the Heart to Predict Right Ventricular Failure After Left Ventricular Assist Device Impl...T.S. Kato, Maryjane Farr, Paul Christian Schulze, Mathew S. Maurer, Khurram Shahzad
The American Journal of Cardiology. 2012-01-15 - 2 citationsHealthcare disparities in heart failure patients (with and without type 2 diabetes) and use of sodium glucose co-transport inhibitors (SGLT2-i).Shivank Madan, Muhammad Farooq, Karim Diab, Angelos Arfaras Melainis, Katherine E. DiPalo
Endocrine. 2021-11-09
Journal Articles
- Analysis of the INTERMACS Post-LVAD RVF Definition and Severe RVF in a Multi-Institutional Retrospective Cohort StudySakima A Smith, Daniel Pinkhas, Ulrich P Jorde, Daniel B Sims, Journal of Cardiac Failure
- A Multi-Institutional Retrospective Cohort Study of the Pulmonary Artery Pulsatility Index's Ability to Predict Post-LVAD Implant Right Ventricular Failure and 1-Year ...Sakima A Smith, Daniel Pinkhas, Ulrich P Jorde, Daniel B Sims, Journal of Cardiac Failure
Authored Content
- Lyme Disease and Cardiac Sarcoidosis Management of Associated Ventricular ArrhythmiasSeptember 2018
- Lyme Disease and Cardiac Sarcoidosis Management of Associated Ventricular ArrhythmiasSeptember 2018
Press Mentions
- Ancora Heart’s AccuCinch System Evaluated in Analysis of HFrEF PatientsMarch 22nd, 2023
- Ancora Heart's AccuCinch System Demonstrates Significant Improvement in Quality of Life, Cardiac Structure and Function in Heart Failure PatientsMarch 22nd, 2023
- Similar Transplant Outcomes with Hearts Donated After Circulatory DeathOctober 5th, 2022
- Join now to see all
Grant Support
- Lipoprotein Utilization And Oxidation In CHFNational Heart, Lung, And Blood Institute2007–2010
- LOX-1 ProtocolNational Center For Research Resources2004
- Level Of ACE Inhibition In Heart FailureNational Heart, Lung, And Blood Institute2003
- Level Of ACE Inhibition In Heart FailureNational Heart, Lung, And Blood Institute1999–2002
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: